Cord-blood respiratory syncytial virus antibodies and respiratory health in first 5 years of life.

Mari D TakashimaKeith GrimwoodPeter D SlyStephen B LambertKeith J ChappellDaniel WattersonPaul YoungMerci KuselBarbara HoltPatrick HoltRobert S Ware

Published in: Pediatric pulmonology (2021)

Higher levels of cord-blood RSV-NA did not protect against RSV infections during the first 6-months-of-life, time-to-first RSV-ARI, or wheeze or asthma in the first 5 years of life. Additional strategies to control RSV-related illness in childhood are needed.

Keyphrases

respiratory syncytial virus
cord blood
respiratory tract
healthcare
public health
chronic obstructive pulmonary disease
mental health
lung function
cystic fibrosis